Form 4: Guardant Health's Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
John G. Saia, Chief Legal Officer of Guardant Health, reports the acquisition and disposal of common stock and restricted stock units to meet tax obligations.
Summary
- On October 1, 2024, John G. Saia, the Chief Legal Officer of Guardant Health, executed transactions involving the company's common stock and restricted stock units.
- Saia acquired 974 shares of common stock and 6,569 shares of common stock through the vesting of restricted stock units.
- He also disposed of 3,824 shares to cover tax withholding obligations related to the vesting of restricted stock units at a price of $22.12 per share.
- Following these transactions, Saia directly owns 32,950 shares of common stock.
- Saia also holds 7,792 restricted stock units from a 2022 grant and 13,338 restricted stock units from a 2023 grant.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The transactions reported are typical for executives receiving stock-based compensation and managing their tax obligations.
- Similar filings can be observed for executives at comparable companies in the healthcare and biotechnology sectors, such as Exact Sciences or Illumina.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
- The filing provides transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock transactions (acquisition and disposal). |
| 10/02/2024 | Date of signature for the Form 4 filing. |
| 11/07/2022 | Date of restricted stock unit award grant that vests over four years. |
| 12/13/2023 | Date of restricted stock unit award grant that vests over three years. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.